Doxacurium vs. Pancuronium.
Kantor
G S
GS
Hoffman
W D
WD
Popovich
M J
MJ
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D007362:Intensive Care Units; D007546:Isoquinolines / Q000191:economics*; D003473:Neuromuscular Nondepolarizing Agents / Q000191:economics*; D010197:Pancuronium / Q000191:economics*
D007546:Isoquinolines; D003473:Neuromuscular Nondepolarizing Agents; D010197:Pancuronium; C049429:doxacurium